Intervention

Naltrexone-Bupropion Combination

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions5

Lead sponsors shown3

Clinical trials

3 shown

Weight Loss Study: Genetics and Response to Naltrexone/BupropionNCT05919797 · 2023-06-08

Use of Mysimba in Patients With Weight Regain After Bariatric SurgeryNCT04902625 · 2023-03-21

Study of the Cardiometabolic Effects of Obesity PharmacotherapyNCT04575194 · 2020-09-08

Common conditions

Obesity2 Bariatric Surgery Candidate1 Blood Pressure1 Medication Persistence1 Obesity, Morbid1

Leading sponsors

Columbia University1 National and Kapodistrian University of Athens1 Zuyderland Medisch Centrum1

Trial status mix

UNKNOWN2

RECRUITING1

Phase mix

PHASE43

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.